Table 2.
Variable | Number of studies | Effect size (95% CI) | I2 (%) | |
---|---|---|---|---|
Lockdown period | Yes | 5 | 13.18 (4.72–21.65) | 82.8 |
No | 66 | 13.19 (11.59–14.79) | 79.9 | |
Gender group | Both genders | 61 | 13 (11.35–14.64) | 82.9 |
Female only | 6 | 14.89 (5.58–24.20) | 83.8 | |
Male only | 4 | 16.79 (10.51–23.07) | 0 | |
Participant groups | General population | 61 | 13.30 (11.63–14.97) | 82.6 |
Healthcare professionals | 10 | 13.11 (8.64–18.13) | 82.1 | |
Overall estimated prevalence | 73 | 13.21 (11.71–14.72) | 82.4 |